Binimetinib
DrugBank ID: DB11967
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| metastatic melanoma | 0.9906 | KG+DL |
| choroideremia | 0.9863 | DL |
| non-cutaneous melanoma | 0.9860 | DL |
| epithelioid cell melanoma | 0.9857 | DL |
| eyelid melanoma | 0.9854 | DL |
| scrotum melanoma | 0.9842 | DL |
| CDK4 linked melanoma | 0.9819 | DL |
| acral lentiginous melanoma (disease) | 0.9819 | DL |
| amelanotic skin melanoma | 0.9819 | DL |
| balloon cell malignant melanoma | 0.9819 | DL |
| lentigo maligna melanoma | 0.9819 | DL |
| malignant melanoma of the mucosa | 0.9819 | DL |
| nodular malignant melanoma | 0.9819 | DL |
| superficial spreading melanoma | 0.9819 | DL |
| choroidal dystrophy, central areolar | 0.9816 | DL |
| intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency | 0.9796 | DL |
| amyotrophic lateral sclerosis | 0.9175 | DL |
| bilateral parasagittal parieto-occipital polymicrogyria | 0.9169 | DL |
| Mills syndrome | 0.9104 | DL |
| amyotrophic lateral sclerosis, susceptibility to | 0.9068 | DL |
| axial spondylometaphyseal dysplasia | 0.9050 | DL |
| amyotrohpic lateral sclerosis type 22 | 0.9004 | DL |
| lower motor neuron syndrome with late-adult onset | 0.8948 | DL |
| lethal arthrogryposis-anterior horn cell disease syndrome | 0.8943 | DL |
| trichomegaly-retina pigmentary degeneration-dwarfism syndrome | 0.8914 | DL |
| monomelic amyotrophy | 0.8842 | DL |
| autosomal dominant mitochondrial myopathy with exercise intolerance | 0.8775 | DL |
| borderline ovarian serous tumor | 0.8319 | DL |
| poliomyelitis | 0.8277 | DL |
| rete ovarii cystadenoma | 0.8241 | DL |
| ovarian mucinous cystadenofibroma | 0.8222 | DL |
| malignant ovarian Brenner tumor | 0.8204 | DL |
| ovarian papillary cystadenoma | 0.8187 | DL |
| serous neoplasm | 0.8174 | DL |
| ovarian benign neoplasm | 0.8163 | DL |
| mucinous ovarian cystadenoma | 0.8154 | DL |
| ovarian surface papilloma | 0.8114 | DL |
| polyclonal hypergammaglobulinemia | 0.7988 | DL |
| mucinous ovarian cancer | 0.7786 | DL |
| monoclonal paraproteinemia disease | 0.7771 | DL |
| melanocytic skin neoplasm | 0.7723 | DL |
| spindle cell melanoma | 0.7684 | DL |
| desmoplastic melanoma | 0.7676 | DL |
| melanocytic neoplasm | 0.7674 | DL |
| ovarian clear cell cancer | 0.7504 | DL |
| systemic mastocytosis | 0.7468 | DL |
| metastatic neoplasm | 0.7395 | DL |
| malignant spiradenoma | 0.7394 | DL |
| Smouldering systemic mastocytosis | 0.7385 | DL |
| mastocytoma | 0.7350 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.